Uterine cervical cancer is one of the most common malignan cies that occur in women. With the widespread use of a screen ing method, the mortality of cervical cancer has been greatly de creased and the early detection of it has become possible. None theless, the cervical cancer remains one of the major health pro blems in women.
There are several histological types of cervical cancer. The two most common types of cervical cancer include squamous cell carcinoma (SCC) and adenocarcinoma. SCC accounts for appro ximately 80% of total cases of cervical cancer. 1 The most well known cause of cervical cancer is human papillomavirus (HPV). Over 100 types of HPV have been introduced to date. 2 High risk HPV is known as the most important factor in cervical car cinogenesis. 1 It is also well known that highgrade squamous intraepithelial lesion (HSIL) predate the onset of invasive cervi cal cancer. In only a small portion of women with highrisk HPV, however, cervical cancer occurs. Little is known about the ge nomic alterations during transition from HSIL to invasive can cer. In an effort to clarify the pathogenesis of cervical cancer, studies have been conducted focusing other causative events than HPV infections. 3, 4 It is known that HPV stimulates the cell cycle by interfering with the function of Rb and p53 in host cells. 1 In particular, its two viral proteins, E6 and E7, play a key role in the pathogenesis of uterine cervical cancer. These viral proteins have oncogenic effects, of which the centrosome dupli cation and genome instability can result in the alteration of copy number in the genome of host cells.
The alteration of copy number is one of mechanisms by which oncogenes are activated. As a good example, two oncogenes such as N-myc and erbB2/neu are activated by the increased copy num ber. The clinical significance of the activation of these oncogenes has been verified in cases of neuroblastoma and breast cancer in the corresponding order. 5, 6 In addition, the role of the alteration of copy number in carcinogenesis has been reported to be of clinical significance in other several human malignancies in cluding lung cancer, prostate cancer, and colorectal cancer. 79 To date, a comparative genomic hybridization (CGH) has been used to identify genomewide changes in the copy number in Background: About 10% of high-grade squamous intraepithelial lesions (HSILs) progress to invasive carcinomas within 2-10 years. By delineating the events that occur in the early stage of the invasion, the pathogenesis of cervical cancer could be better understood. This will also propose the possible methods for inhibiting the tumor invasion and improving the survival of patients. Me thods: We compared the genomic profiles between the HSIL and the invasive squamous cell carcinoma (SCC) using an array comparative genomic hybridization. Using recurrently altered genes, we performed a principal component analysis to see variation of samples in both groups. To find possibly affected pathways by altered genes, we analyzed genomic profiles with the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway database and GOEAST software. Results: We found 11q12.3 and 2p24.1 regions have recurrent copy number gains in both groups. 16p12-13 and 20q11-13 regions showed an increased copy number only in cases of HSIL. 1q25.3 and 3q23-29 regions showed copy number gains only in cases of SCC. Altered genes in the SCC group were related to the mitogen-activated protein kinase signaling pathway and the RNA transport. Altered genes in the HSIL group were related to the ubiquitin mediated proteolysis and cell adhesion molecules. Conclusions: Our results showed not only that gains in 11q12.3 and 2p24.1 were early events occurring in the premalignant lesions and then maintained in cases of SCC but also that gains in 1q25.3 and 3q23-29 were late events occurring after invasion in those of SCC.
cases of cervical cancer. Due to a lower resolution of metaphase chromosome CGH, it gives the information about the cytoband level. In addition, it is difficult to detect the alterations of the narrow region. Since an array CGH using BAC/PAC and oligo nucleotide probes was first introduced, the resolution of CGH has been improved to such a sufficient extent that even the chan ges limited to specific genes or exons could be detected. 10 Up to present, there are several published studies about the alteration of copy number. 3, 1115 In most of these studies, the flu orescent in situ hybridization (FISH) or CGH have been used to detect any changes in cases of cervical cancer.
Due to the limitation of useful research modalities, however, most of the studies have reported that the alterations occurred in both very wide and various regions. It is therefore difficult to delineate their genetic contribution to the pathogenesis of cer vical cancer. It has been reported that deletions at 3p and am plifications of 3q are associated with HPV16. 1 It has been re ported that there are deletions at 2p, 2q34q36, 3p14, 4 and 6p and gains at 1, 3q, 5ptel, 5p15.2 and 5p13 in cases of cervical cancer. 1316 According to some reports, a certain type of the al teration of copy number is detected in the specific stages of cer vical cancer. Gain of chromosome arm 3q is consistently found in cases of advancedstage cervical carcinomas. 17 Losses of 3p, 11q, 6q and 10q and gain of 3q are frequently detected in the primary cervical tumor according to lymph node status. 18 Gain of 3q and loss of 11q are early events in the progression of cervi cal cancer. 19 Some of alterations have been reported to be of clin ical significance. 9p deletions are more frequent in cases of car cinoma with a lymph node metastasis. In addition, losses of chromosome 11p and 18q are associated with a poor prognosis in cases of cervical carcinoma without a lymph node metasta sis. 20 It has been reported that gain of chromosome 3q is associ ated with the transition from severe dysplasia to invasive carci noma of the uterine cervix. 21 But there were no studies focusing on the genomic difference between HSIL and invasive SCC (stage IIb) of uterine cervix using a highresolution array CGH. The morbidity and mortality of the uterine cervical cancer are close ly related to the invasion and metastasis of cancer cells. The dif ference between HSIL and invasive SCC should be clearly delin eated, which will provide clues about the pathogenesis of inva sion in cases of cervical cancer.
Given the above background, we conducted this study to com pare the genomic profiles and the differences in the genetic path way and gene ontology between HSIL and SCC using an array based CGH by which changes in gene level can be detected.
MATERIALS AND METHODS

Primary tumor tissues
In eight cases of uterine cervix tissues, the tissue samples were fixed in a formalin solution and then prepared into paraffinem bedded sections (FFPE). The protocol of the current study was approved by the Institutional Review Board (IRB) (CUMC10 U917) of the Catholic University of Korea, College of Medi cine. These eight cases consisted of four cases of HSIL and an other four cases of invasive SCC (Table 1) .
Genomic DNA extraction
Unstained tissue sections were cut from the paraffin blocks and then deparaffinized with xylene twice. Normal areas of cer vical tissues were removed from the sections using knife blades. The remaining tissues were collected in 1.5 mL microtubes and then digested for 72 hours in the dry chamber, where the tem perature was set at 58°C, using Proteinase K (Invitrogen, Carls bad, CA, USA) in ATL buffer (Qiagen, Valencia, CA, USA) with overlaid mineral oil (SigmaAldrich, St. Louis, MO, USA) that was applied to hinder the evaporation and concentration of the buffer. After the tissue digestion, genomic DNAs were extract ed using DNeasy blood and tissue kit (Qiagen) according to the manufacturer's protocol. The concentration of the DNA was measured using NanoDrop (Thermo Scientific, Wilmington, DE, USA) and the integrity of the DNA was checked with a 1% agarose gel electrophoresis.
DNA fragmentation
Usually the genomic DNA extracted from FFPE tissue is partially degraded and chemically modified. 22 The FFPE DNA produces a highlevel of noise with standard array CGH proto col. To minimize the level of noise in an array CGH data, ran dom fragmentation method using Shrimp Recombinant DNase (Affymetrix, Santa Clara, CA, USA) was exploited. 22 Briefly, a 2.5 μg of extracted DNA and a 1 μg of reference DNA (Pro mega, Madison, WI, USA) were digested with the Shrimp Re combinant DNase (Affymetrix) to get DNA fragments of 200 to 400 bp in size.
Array CGH
Digested fragments of extracted DNA and reference DNA were labeled with Cyanine5 and Cyanine3 dUTP, respectively, using the Bioprime array CGH genomic labeling system (Invi trogen). After labeling reaction, the amount of labeled product and the efficiency of labeling were measured using Nanodrop (Thermo Scientific). Each labeled DNA was cohybridized at an amount of 4 μg, identical to that of labeled reference DNA, to the 4×44K human aCGH array platform (Agilent Technolo gies, Santa Clara, CA, USA). Hybridization was performed at 65°C, for which the array chamber was rotated at 20 rpm for 24 hours. Then the arrays were washed according to the manufac turer's instructions. Microarray slides were scanned on a Ge nePix 4000B microarray scanner (Molecular Devices, Sunny vale, CA, USA). The scanned images were analyzed using Fea ture Extraction software (Agilent Technologies).
Microarray data analysis
To define segments with an altered copy number, we used the aberration detection method 2 (ADM2) algorithm with a threshold of 6 using DNA analytics software (Agilent Technol ogies). 23 To minimize false positives, we excluded aberrations spanning less than three consecutive probes from further analy sis. To focus on recurrent changes in each group, we used aber rations found in at least two cases (50%) of each group. Besides, we used R 2.13.1 software (R Foundation for Statistical Com puting, Vienna, Austria) and Matlab 7.12 software (Mathworks, Natick, MA, USA) for statistical calculations and graphical pre sentations.
Real-time polymerase chain reaction (PCR) of syndecan1 (SDC1) gene
Of the samples that showed an increased copy number of SDC1 on an array CGH, three cases were selected to confirm the copy number gain of SDC1 in the cervical lesion. A 20 ng of genomic DNA extracted from the cervical lesion was used for each reaction. SYBR Premix Ex Taq (Takara Bio Inc., Shiga, Japan) was used to amplify target (SDC1) and reference (beta actin, ACTB) genes using a LightCycler 480 II (Roche, Rot kreuz, Switzerland). We designed two pairs of primers for SDC1 to detect copy number of two regions (exon 2 and exon 3) of SDC1 and one pair for ACTB as reference. The following oligo nucleotides were used as the primer: SDC12F (exon 2) 5´GTTTTTGCAACGGCTAAGGA3´; SDC12R (exon 2) 5´TCTACTGCCGGATTCCTCTC3´; SDC13F (exon 3) 5´CGGCCAAGCCTTTACTCATA3´; SDC13R (exon 3) 5´AGCCGGAGAAGTTGTCAGAG3´; ACTBF 5´AGAAAATCTGGCACCACACC3´; ACTBR 5´AACGGCAGAAGAGAGAACCA3´.
After the preincubation at 95°C for 5 minutes, 45 cycles of the PCR (95°C for 30 seconds, 60°C for 30 seconds, and 72°C for 30 seconds) were performed. Then, the melting curves were analyzed to confirm specific PCRs; all samples were performed in triplicate. We used pooled genomic DNA extracted from the stromal tissues in the same cases as a calibrator. We used the E method of LightCycler 480 II (Roche) to calculate template con centration, where we normalized the copy number of the target and reference using the calibrator.
Pathway analysis
To find possibly affected pathways consisting of altered genes in cases of cervical cancer, we searched the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway database (http://www. genome.jp/kegg/pathway.html).
Gene ontology (GO) analysis
To analyze a set of genes with commonly altered copy num bers based on a gene ontology, we used Gene Ontology enrich ment analysis software toolkit (GOEAST). 24 The list of gene symbols showing a recurrent aberration of the copy number was submitted to the GOEAST. Of the GO term IDs that the GO EAST identified from the list, those with pvalue of <0.05 were considered to be statistically significant.
RESULTS
Distribution of the alteration of copy number
In eight cases of cervical cancer, we found 18,472 microarray probes showing the alteration of copy number. To find recur rent aberrations in each group, we collected aberrations detect ed in at least two cases of each group (Table 2) . No regions show ed a decreased copy number in two or more cases in each group. 11q12.3 (AHNAK, TRIM29) and 2p24.1 (SDC1) were found to show a copy number gain in both the HSIL group and the SCC group (Fig. 1) . The recurrent aberrations of the 16p1213 and 20q1113 regions were found only in the HSIL group and those of the 1q25.3 (IVNS1SBP) and 3q2329 regions were found only in the SCC group.
Principal component analysis (PCA)
To characterize the aberration profiles of the tissue samples of HSIL and SCC, we performed the PCA using all aberration in formation (Fig. 2) . There was a variability in the first, second and third factors forming the principal components, approxi mately showing an orthogonal linear relationship between HSIL and SCC. This indicates that there is a distinct difference in the pattern of the variation between HSIL and SCC based on their genomic profile.
Analysis of the KEGG pathway database
To find possibly affected pathways consisting of altered genes in cases of cervical cancer, we searched the KEGG pathway da tabase ( Table 3 ). The mitogenactivated protein kinase signal ing pathway is found in genes with an aberration of the copy number in cases of SCC. In cases of HSIL with an alteration of the copy number, pathways related to ubiquitinmediated pro teolysis and cell adhesion molecules were found. RNA transport pathway was found in both groups.
GO analysis
Using the GOEAST, we found 757 significant GO term IDs from the list of genes with an alteration of the copy number only in the SCC group. We also found 407 GO term IDs from the list of genes with an alteration of the copy number in both groups. Of the GO term IDs that had been found, representative can cerrelated IDs are represented in Tables 4 and 5 .
The alteration of copy number of SDC1 gene
Of the genes with an aberration of the copy number, we were interested in SDC1 whose gene product is involved in the cell binding, cytoskeletal organization and might play a role in the tumor invasion and metastasis of the tumor. To confirm the dose of an alteration of the copy number in SDC1 gene, we performed the realtime PCR. There three cases of an increased copy num ber in the region of exon 2 but not in that of exon 3 (Fig. 3) .
DISCUSSION
In the current study, we screened whole genomes with any recurrent alterations of the copy number in cases of cervical SCC. We also analyzed a set of genes with an alteration of the copy number using bioinformatics database and tools. Our results were partly in agreement with previous reports about cervical cancer. Of the alterations of the copy number that have been re ported up to present, gains of 1q and 3q are frequently men tioned on a variety of reports about cervical cancer. 3, 11, 12 Our re sults showed that the gain of 3q was a pivotal aberration during the transition from HSIL to invasive SCC. 21 Using an array CGH, we narrowed down the region to 3q2329 and thereby detected another recurrent aberration of IVNS1ABP during the above transition. By contrast, a loss of the copy number has not been frequently reported on the articles. We could not also identify any recurrent losses of the copy number in the current study. This suggests that a gain of the copy number rather than a loss of it might be more relevant in the pathogenesis of cervical can cer.
Advanced cancers are known to have chromosomal instabili ties. Due to the instability, cancer genomes harbor many non specific patterns of the alteration of copy number. By focusing on relatively earlier stage of SCC (International Federation of Genycology and Obstetrics [ FIGO ] stage IIb) and comparing its findings with those of premalignant lesions (HSIL), we were successful in not only demonstrating that there was a difference in the alteration between SCC and HSIL but also minimizing nonspecific patterns of the alterations due to the chromosomal instability.
In cancer cells cultured in in vitro conditions, there is a ten dency to randomly accumulate the alteration of copy number due to chromosomal instabilities. 25 Cell lines, derived from ma lignant cells and grown in culture condition, harbor many non specific patterns of the alteration of copy number. This is seen after the collection of tissue samples from patients. It is there fore probable that reports about the alterations of copy number using cell lines may not be applicable to cancer cells in an in vivo condition. To minimize this bias of cell line study, we used primary malignant and premalignant tissues to investigate the alteration of copy number.
Of the alteration of copy number that had been reported from cervical cancer, some had a prognostic value. Oncostatin M re ceptor (OSMR) frequently shows a copy number gain in cervical cancer, which is associated with adverse clinical outcomes. 26 Our results showed, however, that there was no recurrent aber ration of the copy number in the 5p13.1 region where OSMR is located. This discrepancy can be explained by OSMR gain is a late event in cervical carcinogenesis as the authors 26 mentioned. In their report, more than half of the samples they studied were of FIGO stage IIIb or higher.
Another variant of cervical cancer, cervical adenocarcinoma shows different patterns of the alteration of copy number from SCC. It has been reported that cervical adenocarcinomas have frequent gains at 3q, 17q, 1p, 1q, and 11q. 27 According to these authors, 27 the gain was more commonly seen than the loss of copy number. This was also shown in the current study. In ad dition, 3q2829 gain was found in both the above authors' re ports and our findings.
It is not always observed that the alteration of copy number results in that of gene expression. In about half of total cases, the alteration of the copy number leads to that of the gene ex pression. According to the combination study about the dosage and expression of genes, EPHB2, MMP1, AKT1, ABCC3 genes are both amplified and overexpressed in cases of cervical can cer. 28 To analyze the possible net effect of genomic alterations, we searched for the KEGG pathway database with lists of genes with an alteration of the copy number. In cases of HSIL, genes with an alteration of the copy number are related to both the pathways of ubiquitinmediated proteolysis and adhesion relat ed pathways (Table 3) . HPV E6 induces the rapid degradation of p53 via ubiquitindependent proteolysis. 1 In cases of HSIL, the recurrent copy number gain of genes related to ubiquitin Fig. 3 . Quantification of the alteration of the copy number of syndecan-1 (SDC1) gene using the real-time polymerase chain reaction. There are no reports explaining the reason why there was no persistent presence of the alteration of copy number in cases of HSIL. This might be due to chromosomal instability in malig nant cells.
We have previously reported an increased expression of SDC1 in cases of cervical cancer and its association with a prolonged survival. 29 In the previous report, we performed an interphase FISH to investigate the alteration of copy number of SDC1 but in vain. The detection limit of FISH is generally set at 10 Mbp. Conventional types of the FISH analysis could not therefore de tect any changes with a span of <10 Mbp. If the alteration of copy number of SDC1 gene is partly present, as we shown in the current study, it might not be detected on the FISH analy sis. This explains the discrepancy between our previous report and the current study.
Limitations of the current study are due to a relatively small er number of samples. In the current study, we used only four samples of HSIL and another four samples of invasive SCC. Due to a smaller number of samples, the nature of genomewide al teration of copy number may not be fully explained in cases of HSIL and those of invasive SCC. Nevertheless, we applied strin gent methods to minimize false positives and get pertinent find ings in a total of eight cases of samples. In addition, we have in tentionally excluded any alterations with a span of <three con secutive probes on the genome from the data analysis to resolve two problems. The one problem arises from the FFPE DNA samples. Modified genomic DNA from the FFPE tissues can overrepresent or underrepresent the original copy number of genomic DNA on certain probes. The other problem arises from the probes on microarrays. The probes are well designed and their applicability has been validated by a wide range of research ers, although one or two misbehaving probes may show errone ous results. By ruling out the results obtained from one or two consecutive probes, we resolved both problems mentioned above. It is unavoidable, however, that this strategy increases false neg atives. This might be partly because we found no recurrent loss of the copy number in the current study.
In the current study, we used HSIL and SCC tissues obtained from different patients. If we had compared the tissue samples of HSIL and SCC obtained from the same patient, we could have better shown the direct relationship between the two lesions. In the methods of the current study, we had required a significant amount of genomic DNA with a good quality. But we could not obtained a sufficient amount of genomic DNA from the same patient for an array CGH, the realtime PCR and other necessary procedures for quality control. We collected tissue samples of HSIL and SCC from the different patients, but tried to find recurrent changes in both groups. To our knowledge, an analysis of the recurrent alterations will reduce a bias due to the difference between the individual cases and it will also provide the information about the role of the alteration of copy number that can be generally accepted as the pathogenesis of cervical cancer.
To summarize, our results showed that the recurrent altera tion of copy number occurred in cases of HSIL and those of SCC based on the genomic profiles of both disease entities. The al teration of copy number in AHNAK, TRIM29, and SDC1 genes and that in IVNS1ABP gene were found in premalignant lesions and invasive SCC, respectively.
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